ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab
Clinical trial NCT02891824 · COMPLETED
Trial details
- NCT number
- NCT02891824
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-22
- Primary completion
- 2021-10-15
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.